HYPEST | CADCZ | Healthy Eastern | |||
---|---|---|---|---|---|
Variable | Cases | Controls | Cases | Controls | European individuals1 |
No. of individuals | 470 | 652 | 257 | 413 | 1065 |
Parameters (mean ± SD): | |||||
Age (years)2 | 43.9 (13.0) | 39.0 (4.9) | 51.2 (8.1) | 49.5 (7.4) | 43.7 (9.7) |
Body Mass Index (BMI) (kg/m2) | 28.7 (3.7) | 24.4 (3.3) | 27.9 (3.3) | 25.3 (3.1) | 24.7 (3.1) |
Systolic blood pressure (SBP) (mmHg) | 143.2 (17.6) | 130.0 (22.7) | 136.6 (19.2) | 125.2 (14.0) | 128.5 (12.2) |
Diastolic blood pressure (DBP) (mmHg) | 87.4 (10.6) | 81.0 (14.6) | 85.1 (11.3) | 80.3 (9.3) | 80.0 (8.2) |
Total cholesterol (mmol/liter) | 5.6 (1.1) | 5.0 (1.4) | 5.4 (1.0) | 5.6 (1.0) | 5.4 (1.1) |
High-density lipoprotein (HDL) (mmol/liter) | 1.5 (0.4) | 1.7 (0.5) | 1.2 (0.3) | 1.5 (0.4) | 1.5 (0.4) |
Low-density lipoprotein (LDL) (mmol/liter) | 3.8 (1.0) | 3.3 (1.1) | 3.2 (0.8) | 3.4 (0.9) | 3.3 (0.9) |
Triacylglycerols (mmol/liter) | 1.8 (1.6) | 0.8 (0.3) | 2.1 (1.3) | 1.5 (1.1) | 1.2 (1.1) |
Intima media thickness (IMT) | NA | NA | 0.7 (0.2) | 0.6 (0.2) | NA |
Heart Rate (HR) (bpm) | NA | 71.0 (26.4) | 76.0 (5.6) | 74.8 (5.5) | 74.0 (8.6) |
Medication: | |||||
% of antihypertensive treatment | 75.3% | 0% | 54.5% | 0% | 0% |
% of antilipidemic treatment | 20.2% | 0% | 58.4% | 0% | 0% |